IBDEI1BB ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23500,1,2,0)
 ;;=2^686.9
 ;;^UTILITY(U,$J,358.3,23500,1,5,0)
 ;;=5^Ecthyma gangrenosum
 ;;^UTILITY(U,$J,358.3,23500,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,23501,0)
 ;;=757.39^^148^1481^4
 ;;^UTILITY(U,$J,358.3,23501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23501,1,2,0)
 ;;=2^757.39
 ;;^UTILITY(U,$J,358.3,23501,1,5,0)
 ;;=5^Epidermolysis bullosa acquisita
 ;;^UTILITY(U,$J,358.3,23501,2)
 ;;=^87938
 ;;^UTILITY(U,$J,358.3,23502,0)
 ;;=695.9^^148^1481^7
 ;;^UTILITY(U,$J,358.3,23502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23502,1,2,0)
 ;;=2^695.9
 ;;^UTILITY(U,$J,358.3,23502,1,5,0)
 ;;=5^Erythroderma, exfoliative
 ;;^UTILITY(U,$J,358.3,23502,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,23503,0)
 ;;=709.09^^148^1482^3
 ;;^UTILITY(U,$J,358.3,23503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23503,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,23503,1,5,0)
 ;;=5^Freckles
 ;;^UTILITY(U,$J,358.3,23503,2)
 ;;=Freckles^303313
 ;;^UTILITY(U,$J,358.3,23504,0)
 ;;=709.4^^148^1482^2
 ;;^UTILITY(U,$J,358.3,23504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23504,1,2,0)
 ;;=2^709.4
 ;;^UTILITY(U,$J,358.3,23504,1,5,0)
 ;;=5^Foreign Body Reaction/Granuloma
 ;;^UTILITY(U,$J,358.3,23504,2)
 ;;=Foreign Body Reaction/Granuloma^271943
 ;;^UTILITY(U,$J,358.3,23505,0)
 ;;=698.4^^148^1482^1
 ;;^UTILITY(U,$J,358.3,23505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23505,1,2,0)
 ;;=2^698.4
 ;;^UTILITY(U,$J,358.3,23505,1,5,0)
 ;;=5^Factitial Dermatitis
 ;;^UTILITY(U,$J,358.3,23505,2)
 ;;=^186786
 ;;^UTILITY(U,$J,358.3,23506,0)
 ;;=228.01^^148^1483^1
 ;;^UTILITY(U,$J,358.3,23506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23506,1,2,0)
 ;;=2^228.01
 ;;^UTILITY(U,$J,358.3,23506,1,5,0)
 ;;=5^Hemangioma Skin
 ;;^UTILITY(U,$J,358.3,23506,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,23507,0)
 ;;=705.83^^148^1483^2
 ;;^UTILITY(U,$J,358.3,23507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23507,1,2,0)
 ;;=2^705.83
 ;;^UTILITY(U,$J,358.3,23507,1,5,0)
 ;;=5^Hidradentitis Suppuritiva
 ;;^UTILITY(U,$J,358.3,23507,2)
 ;;=^184621
 ;;^UTILITY(U,$J,358.3,23508,0)
 ;;=704.1^^148^1483^3
 ;;^UTILITY(U,$J,358.3,23508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23508,1,2,0)
 ;;=2^704.1
 ;;^UTILITY(U,$J,358.3,23508,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,23508,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,23509,0)
 ;;=780.8^^148^1483^7
 ;;^UTILITY(U,$J,358.3,23509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23509,1,2,0)
 ;;=2^780.8
 ;;^UTILITY(U,$J,358.3,23509,1,5,0)
 ;;=5^Hyperhidrosis
 ;;^UTILITY(U,$J,358.3,23509,2)
 ;;=^60030
 ;;^UTILITY(U,$J,358.3,23510,0)
 ;;=709.09^^148^1483^6
 ;;^UTILITY(U,$J,358.3,23510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23510,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,23510,1,5,0)
 ;;=5^Hyper/hypopigmentation
 ;;^UTILITY(U,$J,358.3,23510,2)
 ;;=^303313
 ;;^UTILITY(U,$J,358.3,23511,0)
 ;;=079.4^^148^1483^5
 ;;^UTILITY(U,$J,358.3,23511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23511,1,2,0)
 ;;=2^079.4
 ;;^UTILITY(U,$J,358.3,23511,1,5,0)
 ;;=5^Human Papillomavirus
 ;;^UTILITY(U,$J,358.3,23511,2)
 ;;=^295791
 ;;^UTILITY(U,$J,358.3,23512,0)
 ;;=708.9^^148^1483^4
 ;;^UTILITY(U,$J,358.3,23512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23512,1,2,0)
 ;;=2^708.9
 ;;^UTILITY(U,$J,358.3,23512,1,5,0)
 ;;=5^Hives
 ;;^UTILITY(U,$J,358.3,23512,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,23513,0)
 ;;=695.89^^148^1484^2
 ;;^UTILITY(U,$J,358.3,23513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23513,1,2,0)
 ;;=2^695.89
 ;;^UTILITY(U,$J,358.3,23513,1,5,0)
 ;;=5^Intertrigo
 ;;^UTILITY(U,$J,358.3,23513,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,23514,0)
 ;;=684.^^148^1484^1
